| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.07 | 0.1 |